RIXUBIS
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RIXUBIS, covering 2022-08-30 to 2024-11-27. Get the full timeline:
Most recent: EMA Authorised: Rixubis (nonacog gamma) — Baxalta Innovations GmbH
3 regulatory and trial events tracked for RIXUBIS, covering 2022-08-30 to 2024-11-27. Get the full timeline:
Most recent: EMA Authorised: Rixubis (nonacog gamma) — Baxalta Innovations GmbH